表紙:A型ボツリヌス毒素製剤の中国市場:2020年~2024年
市場調査レポート
商品コード
962451

A型ボツリヌス毒素製剤の中国市場:2020年~2024年

Investigation Report on China's Botulinum Toxin Type A Market, 2020-2024

出版日: | 発行: China Research and Intelligence | ページ情報: 英文 40 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=114.72円
A型ボツリヌス毒素製剤の中国市場:2020年~2024年
出版日: 2020年09月30日
発行: China Research and Intelligence
ページ情報: 英文 40 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 目次
概要

中国におけるA型ボツリヌス毒素製剤の年間売上高は、2015年の1億488万人民元から、2019年には1億7,654万人民元まで増加し、2015年~2019年のCAGRで13.9%の成長を遂げました。

当レポートでは、中国のA型ボツリヌス毒素製剤市場について調査分析し、状況、市場規模、主要メーカー、市場競合、小売価格、市場の見通しについて、体系的な情報を提供しています。

目次

第1章 A型ボツリヌス毒素製剤の関連概念

  • A型ボツリヌス毒素製剤の適応症
  • 中国におけるA型ボツリヌス毒素製剤の開発
  • 中国におけるA型ボツリヌス毒素製剤の政府承認

第2章 中国におけるA型ボツリヌス毒素製剤の販売

  • 中国におけるA型ボツリヌス毒素製剤の売上高
    • 総売上高
    • 売上高:地域別
  • 中国におけるA型ボツリヌス毒素製剤の販売数量
    • 総販売数量
    • 販売数量:地域別
  • 中国におけるA型ボツリヌス毒素製剤の販売:剤形別

第3章 中国におけるA型ボツリヌス毒素製剤の主要メーカーの分析

  • A型ボツリヌス毒素製剤の主要メーカーの市場シェアに関する分析
    • 市場シェア:売上高別
    • 市場シェア:販売数量別
  • Allergan
  • Lanzhou Institute of Biological Products Co., Ltd.
  • 中国で違法に販売されたA型ボツリヌス毒素製剤の分析

第4章 中国におけるA型ボツリヌス毒素製剤の価格

  • 中国におけるA型ボツリヌス毒素製剤の平均価格
  • AllerganのA型ボツリヌス毒素製剤の平均価格
  • Lanzhou Institute of Biological Products Co., Ltd.のA型ボツリヌス毒素製剤の平均価格

第5章 中国のA型ボツリヌス毒素製剤市場の見通し

  • 中国のA型ボツリヌス毒素製剤市場の発展に影響を与える主な要因
  • 市場規模の予測
  • 市場動向の予測
目次
Product Code: 2009437

On Apr. 15, 2002, Botulinum Toxin Type A was approved by the FDA as a medical cosmetic that is injected to temporarily improve the appearance of moderate to severe glabellar lines. Later, some generic drugs appeared on the market. In addition to the imported Botulinum Toxin Type A (trade name: Botox) produced by Allergan, the Botulinum Toxin Type A products in China also include Botulinum Toxin Type A (trade name: Hengli) developed by Lanzhou Institute of Biological Products Co., Ltd.

According to CRI's market research, Botulinum Toxin Type A has been growing rapidly since it entered China. From 2015 to 2019, its annual sales value increased from less than CNY104.88 million to CNY176.54 million, representing a CAGR of 13.9%.

In China, the medical use of Botulinum Toxin Type A is to treat adult blepharospasm and prosopospasm and some strabismuses, especially acute paralytic strabismus, concomitant strabismus, strabismus caused by endocrine diseases, and the strabismus that cannot be corrected surgically for those aged 12 and above. The incidence of facial neuropathy is increasing in China. Many people are attacked by prosopospasm when they are over-stressed or fatigued. Seeing global annual incidence of about 0.003%, facial neuropathy is more common in women than in men, and more common in middle-aged and elderly people than in people from other age groups.

However, more users of Botulinum Toxin Type A are women who pursue a thin face or less wrinkles. With more than 10 million cosmetic surgeries every year, the market size of medical beauty in China has exceeded USD 15 billion in 2019 and is still growing. As the demand for Botulinum Toxin Type A is expanding, some medical institutions and beauty salons have begun to inject Botulinum Toxin Type A smuggled from South Korea, France, Germany, etc. for their customers. Although the Chinese government only approved the sale of Botox and Hengli, smuggled Botulinum Toxin Type A products are easily available in China.

It is expected that, with the development of China's economy, the rise of income, and the change of consumption habit, Chinese people will spend more in medical beauty, and the market size of Botulinum Toxin Type A will continue to grow in China in 2020-2024.

Topics Covered:

  • Status of China's medical beauty market
  • Sales value and volume of Botulinum Toxin Type A in China 2015-2019
  • Sales value and volume of Botulinum Toxin Type A in China by regions and manufacturers
  • Prices of Botulinum Toxin Type A in China 2015-2019
  • Competition on China's Botulinum Toxin Type A market
  • Major factors influencing the development of China's Botulinum Toxin Type A market
  • Prospect of China's Botulinum Toxin Type A market from 2020 to 2024

Table of Contents

Table of contents

1 Relevant Concepts of Botulinum Toxin Type A

  • 1.1 Indications for Botulinum Toxin Type A
  • 1.2 Development of Botulinum Toxin Type A in China
  • 1.3 Governmental Approval of Botulinum Toxin Type A in China

2 Sales of Botulinum Toxin Type A in China, 2015-2019

  • 2.1 Sales Value of Botulinum Toxin Type A in China
    • 2.1.1 Overall Sales Value
    • 2.1.2 Sales Value by Region
  • 2.2 Sales Volume of Botulinum Toxin Type A in China
    • 2.2.1 Overall Sales Volume
    • 2.2.2 Sales Volume by Region
  • 2.3 Sales of Botulinum Toxin Type A by Dosage Form in China, 2015-2019

3 Analysis on Major Manufacturers of Botulinum Toxin Type A in China, 2015-2019

  • 3.1 Analysis on Market Share of Major Manufacturers of Botulinum Toxin Type A
    • 3.1.1 Market Share by Sales Value
    • 3.1.2 Market Share by Sales Volume
  • 3.2 Allergan
    • 3.2.1 Enterprise Profile
    • 3.2.2 Sales of Allergan's Botulinum Toxin Type A in China
  • 3.3 Lanzhou Institute of Biological Products Co., Ltd.
    • 3.3.1 Enterprise Profile
    • 3.3.2 Sales of Lanzhou Institute of Biological Products Co., Ltd.'s Botulinum Toxin Type A in China
  • 3.4 Analysis on Botulinum Toxin Type A Illegally Sold in China

4 Prices of Botulinum Toxin Type A in China, 2019-2020

  • 4.1 Average price of Botulinum Toxin Type A in China, 2019-2020
  • 4.2 Average price of Allergan's Botulinum Toxin Type A (Botox)
  • 4.3 Average price of Lanzhou Institute of Biological Products Co., Ltd. 's Botulinum Toxin Type A (Hengli)

5 Prospect of China's Botulinum Toxin Type A Market, 2020-2024

  • 5.1 Major Factors Influencing Development of China's Botulinum Toxin Type A Market
  • 5.2 Forecast on Market Size
  • 5.3 Forecast on Market Trend

Table of Selected Charts

  • Chart Comparison of Two Botulinum Toxin Type A Products in China
  • Chart Governmental Approval of Allergan's Botulinum Toxin Type A in China
  • Chart Governmental Approval of Lanzhou Bio-technology Development Co., Ltd.'s Botulinum Toxin Type A in China
  • Chart Sales Value of Botulinum Toxin Type A in China, 2015-2019
  • Chart Sales Value of Botulinum Toxin Type A in Parts of China, 2015-2019(Unit in CNY million)
  • Chart Sales Volume of Botulinum Toxin Type A in China, 2015-2019
  • Chart Sales Volume of Botulinum Toxin Type A in Parts of China, 2015-2019 (Unit in thousand vials)
  • Chart Sales Value of Botulinum Toxin Type A Injections in China, 2015-2019
  • Chart Sales Volume of Botulinum Toxin Type A Injections in China, 2015-2019
  • Chart Market Share of Top 2 Manufacturers of Botulinum Toxin Type A by Sales Value in China, 2015-2019
  • Chart Profile of Allergan
  • Chart Sales Value of Allergan's Botulinum Toxin Type A in China, 2015-2019
  • Chart Sales Volume of Allergan's Botulinum Toxin Type A in China, 2015-2019
  • Chart Profile of Lanzhou Institute of Biological Products Co., Ltd.
  • Chart Sales Value of Lanzhou Institute of Biological Products Co., Ltd.'s Botulinum Toxin Type A in China, 2015-2019
  • Chart Sales Volume of Lanzhou Institute of Biological Products Co., Ltd.'s Botulinum Toxin Type A in China, 2015-2019
  • Chart Prices of Allergan's Botulinum Toxin Type A (Botox) in Parts of China, 2019-2020
  • Chart Prices of Lanzhou Institute of Biological Products Co., Ltd.'s Botulinum Toxin Type A (Hengli) in Parts of China, 2019-2020
  • Chart Forecast on Sales Value of Botulinum Toxin Type A in China, 2020-2024
  • Chart Forecast on Sales Volumes of Botulinum Toxin Type A in China, 2020-2024